HYQVIA is indicated for the treatment of primary immunodeficiency (PI) in adults. HYQVIA is for subcutaneous use only. Safety and efficacy of chronic use of Recombinant Human Hyaluronidase in HYQVIA have not been established in conditions other than PI.

Infuse monthly.1*
Live daily.

Meet Silas.

Full-time student. Aspiring psychological researcher. Real HyQvia patient. Between studying, working and traveling to attend conferences, he doesn’t have a moment to spare. HyQvia helps him focus less on managing his treatment and more on living his life.

For adults with primary immunodeficiency (PI), there's more to life than managing their treatment schedule. HYQVIA offers monthly* subcutaneous immune globulin (SCIG) treatments to help patients maximize time between infusions.

Learn more about HYQVIA Learn more about HYQVIA

*Every 3 or 4 weeks.

About HYQVIA

Understand how HYQVIA can help your patients maximize time between infusions.

Read more about HYQVIA

Dosing and administration

Information about HYQVIA dosing and administration, including flexible infusion options and tools for patients.

See dosing information

Hello HYQVIA

Determine if HYQVIA is right for your eligible patients with our free trial program.

Learn more

Access and support

Support for your patients throughout their treatment.

Discover resources
Reference:
  1. HYQVIA [prescribing information]. Lexington, MA: Baxalta US Inc.